TYBR Health, Inc. — SEC Form D Filing
TYBR Health, Inc. filed an SEC Form D on July 22, 2026, reporting $14.35M raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- July 22, 2026
- Amount reported
- $14.35M
- Round stage
- Pre-Seed
- Industry
- Medical Devices
- Website
- https://www.tybrhealth.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
After tendon repair surgery, up to 40% of patients experience lifelong mobility limitations due to the body's healing response, leading to a gap between surgical success and functional recovery.
Solution
TYBR Health aims to improve functional recovery for tendon repair patients by addressing the gap between surgical success and the body's healing response, though the specific mechanism is not detailed on the provided content.
Verdict
Investors backed this company primarily due to the clear and substantial downstream consequences of current tendon repair limitations, not the detailed specifics of their proposed solution. The implicit bet was on the team's ability to translate a general medical need into a clinically viable and regulatory-approvable device. Upside was inherently limited by the typical development cycles and regulatory hurdles in medical devices, which constrain rapid scale and exit velocity compared to software plays.
Source: SEC EDGAR Form D filing